期刊文献+

^(89)Sr改善晚期肿瘤骨转移患者骨痛的研究 被引量:1

To Improve the Life Quality in Patients with Advanced Stage Tumors Using ^(89)Sr Therapy for Treatment of Their Bone Metastases
下载PDF
导出
摘要 目的探讨89Sr治疗骨转移瘤对晚期肿瘤患者生活质量改善的价值。方法对99m锝 MDP全身骨显像证实有多发性骨转移瘤者 6 1例 ,使用89Sr治疗后 ,观察治疗前后疼痛缓解程度、疼痛发作频率及骨转移瘤显像的变化。结果6 1例中 4 3例疼痛出现不同程度缓解 ,缓解率为 70 .5 % (4 3/ 6 1例 )。 6例 (均为轻中度疼痛病例 )疼痛完全消失 ,消失率 9.8% (6 / 6 1例 ) ;1 3例剧痛患者均出现缓解。治疗前后差异有显著性 (u=4 .6 36 ,P <0 .0 1 )。治疗后 4 5例疼痛发作频率明显降低 (u =3.6 4 2 ,P <0 .0 1 )。无须用易成瘾类镇痛剂 ,生活质量得到改善。 6 1例从显像复查对比中 ,发现 1 8例的病灶有不同程度的缩小和减少。病灶好转率为 2 8.6 %。 Objectives To evaluate the clinical significance of 89 Sr therapy in treatment of bone metastasis for improving the life quality of patients with advanced stage tumors.MethodsDisseminated bone metastases were confirmed by 99m Tc MDP systemic bone imaging in sixty one patients. The changes of pain remission, pain frequency and bone images before and after 89 Sr therapy were compared in all cases.ResultsForty three cases showed pain remission (70.5%), 45 cases displayed distinct reduction of pain frequency (73.7%;u= 3.642 , P<0.01), administration of addictive analgesics was not needed, so their life quality got improved . Different degree of shrinking and decrease in lesions were observed on 99m Tc MDP bone imaging of 18 cases ( 28.6 %). Significant difference existed between symptoms and signs before and after 89Sr therapy (u= 4.636 , P<0.01) .Conclusion 89 Sr is an effective remedy for remission of pain caused by bone metastases in advanced stage tumors.
出处 《医学临床研究》 CAS 2003年第7期484-485,488,共3页 Journal of Clinical Research
关键词 骨转移瘤 骨肿瘤 骨痛 放射疗法 锶89 治疗 生活质量 bone neoplasms/SC bone neoplasms/RT strontium radioisotopes/TU quality of life
  • 相关文献

参考文献4

  • 1范义湘,彭武和,陈仰珍.^(89)SrCl_2治疗骨转移瘤疼痛疗效分析[J].中华核医学杂志,2000,20(5):227-228. 被引量:21
  • 2Turner SL, Gruenewald S, Spry N, et al . Less pain does equal better quality of life following strontium-89 therapy for metastasis prostate cancer[J], Br J Cancer ,2001,84(3) :297-302.
  • 3Tu SM,Millikan RE, Mengistu B, et al . Bone-targeted therapy for advanced and rogen-independent carcinoma of the prostare: a randomised phase II trial[J]. Lancet ,2001, 357:336-341.
  • 4Reddy Ek, Robinson RG, Mansfield CM. ^89Sr for palliation of bone metastases[J]. J Natl Med Assoc ,1986,78: 27-31.

二级参考文献2

共引文献20

同被引文献6

  • 1Giammarile F,Mognetti T,Resche I,Bone pain palliation with strontium-89 in csncer patients with bone metastases[J].QJ NucJ Med,2001,45(1):78-83.
  • 2Turner SL,Gruenewald S,Spry N et al.Less pain dose equal better quality of life follwing strontium-89 therapy for metastases prostate cancer.Br J Cancer,2001,84(3):297-302.
  • 3Lee CK,Aeppli DM,Unger J,et al. ^89Sr chloride (Metastton)for palliative treatment of bone metastases.The University of Minnesota experience[J].Am J Clin Oncol,1996,19(2):102-107.
  • 4Tu SM,Millikan RE,Mengistu B et al.Bone-targeted therapy for advanced and drogen-independent carcinoma of the prostate:a randomized phase Ⅱ risl.Lsncet.2001,357:336-341.
  • 5孙燕.癌症疼痛处理的基本原则[J].中国肿瘤,1999,8(2):55-56. 被引量:72
  • 6殷铁军,鲜于志群,胡长耀.^(89)Sr治疗骨转移癌疼痛研究[J].肿瘤防治研究,2003,30(3):233-235. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部